(11) Involved in Medical Fee Revisions Three Times – Kumamoto Nichinichi Shimbun

The news reported by Kumamoto Nichinichi Shimbun, “(11) Involved in Medical Fee Revisions Three Times,” highlights the continuous and profound impact of medical fee revisions on healthcare institution management. This experience suggests that it is essential not only to respond to revisions but also to formulate medium-to-long-term management strategies, business succession plans, and M&A strategies that anticipate the biennial cycle. It is particularly inferred that maintaining facility standards through economies of scale, distributing the burden of capital investment, and utilizing tax schemes, including transitions to specified medical corporations (Tokutei Iryo Hojin) and social medical corporations (Shakai Iryo Hojin), significantly influence valuation and feasibility during M&A and succession.

The “Repetition” of Medical Fee Revisions Indicates a Long-Term Perspective for M&A and Succession Strategies

The report, “Involved in Medical Fee Revisions Three Times,” reminds healthcare institution managers that medical fee revisions are not one-off events but continuous environmental factors that determine business sustainability. The biennial revision cycle directly impacts healthcare institutions’ revenue structures, available medical services, and ultimately, corporate valuation. When considering M&A or business succession, it is essential not only to analyze past revenue fluctuations caused by revisions in detail but also to predict future revision trends from multiple perspectives and build a management system and business portfolio that can respond to them. In particular, revision items that encourage specific capital investments or system development, such as the recent Medical DX Promotion System Development Surcharge (Iryo DX Suishin Taisei Seibi Kasan), affect post-M&A capital investment plans and PMI strategies. Therefore, the ability to deeply interpret the intent and direction of revisions is required.

Maintaining Facility Standards and Optimizing Investment Efficiency Through M&A-Driven Scale Expansion

The “economies of scale” and “maintaining facility standards” mentioned in the news highlights are extremely important points in M&A for healthcare institutions. Many facility standards related to advanced medical care provision systems and specialized clinical functions presuppose a certain number of beds, staffing, and capital investment. Facility standards that are difficult for individual clinics or small hospitals to maintain can potentially be efficiently maintained or acquired through the integration of multiple healthcare institutions or participation in a medical corporation group via M&A. For example, the requirements for meeting the standards of community medical support hospitals (Chiiki Iryo Shien Byoin) and DPC-eligible hospitals are stringent. It is inferred that by clearing these through M&A, healthcare institutions can strengthen their role in the regional medical care vision (Chiiki Iryo Koso) and secure stable medical fee revenue. Furthermore, by distributing capital investment burdens, such as those for medical DX-related investments and the introduction of expensive medical equipment, across the entire group, individual healthcare institutions can reduce financial risks and enhance investment efficiency.

Financial Impact of Tax Incentives and Corporate Form Conversion on M&A and Succession

“Utilizing tax incentives, including the transition to specified medical corporations (Tokutei Iryo Hojin) and social medical corporations (Shakai Iryo Hojin),” is a crucial factor that cannot be overlooked when considering business succession or M&A for medical corporations. These corporate forms, by applying tax preferential measures, can lead to a reduction in corporate tax burden and, consequently, the optimization of the transferor’s founder’s profit (inheritance tax and gift tax related to equity interests). In particular, the transition from a medical corporation with equity interests to a medical corporation without equity interests (e.g., a fund-contributing medical corporation) is an effective means to separate the director’s personal assets from the corporation’s assets and resolve future inheritance and gift tax issues. For M&A buyers, the reduction of potential tax risks arising from equity interests can positively influence M&A negotiations and valuation. However, changing the corporate form requires a wide range of specialized considerations, including medical law regulations, the complexity of transition procedures, and coordination with existing investors, making early and planned preparation essential.

If you are specifically considering business succession or M&A for a medical corporation or clinic, please utilize our free quick assessment or individual consultation (strict confidentiality, fully success-fee based).